{"id":"https://openalex.org/W4282963193","doi":"https://doi.org/10.1158/1538-7445.am2022-2882","title":"Abstract 2882: Selective activation of CD8+ T cells by a CD8-targeted IL-21 results in enhanced anti-tumor efficacy and safety","display_name":"Abstract 2882: Selective activation of CD8+ T cells by a CD8-targeted IL-21 results in enhanced anti-tumor efficacy and safety","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282963193","doi":"https://doi.org/10.1158/1538-7445.am2022-2882"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-2882","doi":"https://doi.org/10.1158/1538-7445.am2022-2882","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-2882","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Renee Greer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renee Greer","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042017663","display_name":"David V. Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Liu","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049579317","display_name":"Henry Nguyen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry Nguyen","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072395669","display_name":"Ruth Y. Lan","orcid":"https://orcid.org/0000-0002-1898-2271","observed_orcids":["https://orcid.org/0000-0002-1898-2271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruth Lan","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064304128","display_name":"Wei Wei Prior","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Wei Prior","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072450278","display_name":"Meghana Sukthankar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meghana Sukthankar","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079389840","display_name":"Paul B. Mesko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Mesko","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077885583","display_name":"Irene Ni","orcid":"https://orcid.org/0009-0001-1180-3234","observed_orcids":["https://orcid.org/0009-0001-1180-3234"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"irene Ni","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053594470","display_name":"Mike Chin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mike Chin","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043334947","display_name":"Kelly Dare Moynihan","orcid":"https://orcid.org/0000-0001-6200-7863","observed_orcids":["https://orcid.org/0000-0001-6200-7863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly Moynihan","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001016649","display_name":"Ton N. Schumacher","orcid":"https://orcid.org/0000-0003-0517-8804","observed_orcids":["https://orcid.org/0000-0003-0517-8804"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ton Schumacher","raw_affiliation_strings":["2Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015404967","display_name":"Ivana M. Djuretic","orcid":"https://orcid.org/0009-0007-1094-3247","observed_orcids":["https://orcid.org/0009-0007-1094-3247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ivana Djuretic","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Andy Yeung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andy Yeung","raw_affiliation_strings":["1Asher Biotherapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Asher Biotherapeutics, South San Francisco, CA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"2882","last_page":"2882"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3546999990940094,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3546999990940094,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.30709999799728394,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1615000069141388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8619999885559082},{"id":"https://openalex.org/keywords/stat3-activation","display_name":"STAT3 activation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8009999990463257},{"id":"https://openalex.org/keywords/mc38-colon-carcinoma","display_name":"MC38 colon carcinoma","score":0.7129999995231628},{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":0.8349999785423279},{"id":"https://openalex.org/keywords/lymphocyte-trafficking","display_name":"lymphocyte migration","score":0.5059999823570251},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7419999837875366},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.48899999260902405},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.7129999995231628},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6260150074958801},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5870609283447266},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4760199189186096},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4741470217704773},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.471027672290802},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4225137233734131},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4193476736545563},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.4166167676448822},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.24416831135749817},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09069159626960754}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-2882","doi":"https://doi.org/10.1158/1538-7445.am2022-2882","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-2882","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308401731","https://openalex.org/W4388048079","https://openalex.org/W2021070713","https://openalex.org/W2005416198","https://openalex.org/W2141312960","https://openalex.org/W4405134490","https://openalex.org/W2355143179","https://openalex.org/W2982112650","https://openalex.org/W7096806407","https://openalex.org/W2392457462"],"abstract_inverted_index":{"Abstract":[0],"Interleukin-21":[1],"(IL-21)":[2],"is":[3,289,357],"a":[4,245,253,358,379,449],"pleiotropic":[5],"cytokine":[6],"that":[7,116,141,224,252,281,320,355],"activates":[8],"multiple":[9,193],"lymphoid":[10],"and":[11,36,42,96,111,131,145,167,336,370,406,457],"myeloid":[12],"immune":[13,23],"cell":[14,40,316,329],"subsets.":[15],"IL-21":[16,45,70,103,137,204,230,258,350,451],"can":[17,46],"have":[18],"beneficial":[19],"effects":[20,63,302],"on":[21,64,120,155],"anti-tumor":[22,62,213,323,455],"responses":[24,266],"due":[25],"to":[26,29,85,361,396],"its":[27,61,108],"ability":[28],"activate":[30,147],"STAT3":[31,386],"in":[32,75,164,192,208,239,267,303,309,351,388,453],"CD8+":[33,65,121,148,177,314,338,389,445],"T":[34,66,122,149,178,298,315,328,339,390,446],"cells":[35,123,127,150,171,179,340,391,447],"promote":[37],"cytotoxicity,":[38],"memory":[39],"differentiation":[41],"survival.":[43],"However,":[44],"also":[47,344],"induce":[48],"immunosuppressive":[49,98],"effects,":[50,99],"such":[51,403],"as":[52,259,261,378,404],"suppression":[53],"of":[54,94,102,176,228,256,285,295,312,327,398,444,462],"antigen":[55,247],"presentation,":[56],"which":[57,383],"may":[58,392],"directly":[59],"oppose":[60],"cells.":[67,157,182,299],"Although":[68],"recombinant":[69],"did":[71],"show":[72,251],"monotherapy":[73],"activity":[74,119,154],"the":[76,86,91,240,276,293,304,310,463],"clinic,":[77],"overall":[78],"response":[79],"rates":[80],"were":[81,307],"modest.":[82],"In":[83,158,364],"addition":[84],"pharmacological":[87],"sink":[88],"created":[89],"by":[90,107,292,384,401,448],"broad":[92],"expression":[93],"IL-21R":[95],"potential":[97],"clinical":[100],"utility":[101],"was":[104],"further":[105],"limited":[106],"low":[109,260,286],"bioavailability":[110,144,343],"dose-limiting":[112],"toxicities.":[113],"We":[114,134,273],"hypothesized":[115],"maximizing":[117],"IL-21\u2019s":[118],"while":[124,151],"avoiding":[125],"non-CD8":[126,156,181],"would":[128],"enhance":[129],"efficacy":[130,191,214,238,324,369,456],"improve":[132],"tolerability.":[133],"developed":[135],"cis-targeted":[136],"(CD8-IL21)":[138],"fusion":[139,231],"proteins":[140],"exhibit":[142],"improved":[143,342,346,368],"selectively":[146],"exhibiting":[152],"minimal":[153],"vitro":[159,209],"phospho-STAT3":[160],"assays":[161],"with":[162,341],"CD8-IL21":[163,185,211,288,321,332,366],"mouse":[165,184],"splenocytes":[166],"human":[168,335],"peripheral":[169,296],"blood":[170],"showed":[172,223,367],">1000-fold":[173],"selective":[174,333],"activation":[175,294,397,443],"over":[180,348,372],"A":[183,331],"surrogate":[186],"demonstrated":[187,274],"profound":[188],"single":[189,236,254],"agent":[190,237,382],"syngeneic":[194],"tumor":[195,242,246],"models":[196],"at":[197],"considerably":[198],"lower":[199],"doses":[200,227],"than":[201],"an":[202],"untargeted":[203,349,373],"control,":[205],"despite":[206],"similar":[207],"potency.":[210],"mediated":[212,322],"without":[215],"inducing":[216],"body":[217],"weight":[218],"loss.":[219],"Whereas":[220],"prior":[221],"data":[222],"repeated":[225],"high":[226],"tumor-targeted":[229],"protein":[232],"(>3":[233],"mg/kg)":[234],"had":[235],"MC38":[241,271,305],"model":[243,306],"overexpressing":[244],"[1],":[248],"here":[249],"we":[250],"dose":[255,287],"CD8-targeted":[257,450],"0.1":[262],"mg/kg":[263],"induced":[264],"curative":[265,301],"mice":[268],"bearing":[269],"established":[270],"tumors.":[272],"using":[275],"lymphocyte":[277],"migration":[278],"inhibitor":[279],"FTY720":[280],"this":[282],"enhanced":[283,454],"potency":[284],"predominately":[290],"driven":[291],"CD8":[297],"Furthermore,":[300],"elicited":[308],"absence":[311],"substantial":[313],"expansion":[317],"(<1.5-fold)":[318],"suggesting":[319],"through":[325],"modulation":[326],"phenotype.":[330],"for":[334,466],"cynomolgus":[337,352],"exhibited":[345],"tolerability":[347,359],"monkeys,":[353],"showing":[354],"there":[356],"benefit":[360],"CD8-selective":[362],"activation.":[363],"summary,":[365],"safety":[371,458],"IL-21,":[374],"demonstrating":[375],"clear":[376],"promise":[377],"novel":[380],"therapeutic":[381],"activating":[385],"signaling":[387,400],"offer":[393],"complementary":[394],"benefits":[395],"STAT5":[399],"cytokines":[402],"IL-2":[405],"IL-15.Ref:":[407],"1.":[408],"Deng":[409],"et":[410],"al.,":[411],"2020":[412],"Citation":[413],"Format:":[414],"Renee":[415],"Greer,":[416],"David":[417],"Liu,":[418],"Henry":[419],"Nguyen,":[420],"Ruth":[421],"Lan,":[422],"Wei":[423,424],"Prior,":[425],"Meghana":[426],"Sukthankar,":[427],"Paul":[428],"Mesko,":[429],"irene":[430],"Ni,":[431],"Mike":[432],"Chin,":[433],"Kelly":[434],"Moynihan,":[435],"Ton":[436],"Schumacher,":[437],"Ivana":[438],"Djuretic,":[439],"Andy":[440],"Yeung.":[441],"Selective":[442],"results":[452],"[abstract].":[459],"In:":[460],"Proceedings":[461],"American":[464],"Association":[465],"Cancer":[467,478],"Research":[468],"Annual":[469],"Meeting":[470],"2022;":[471],"2022":[472],"Apr":[473],"8-13.":[474],"Philadelphia":[475],"(PA):":[476],"AACR;":[477],"Res":[479],"2022;82(12_Suppl):Abstract":[480],"nr":[481],"2882.":[482]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2022-06-17T00:00:00"}